ALNEV — Neovacs SA Cashflow Statement
0.000.00%
Last trade - 00:00- €0.00m
- -€4.69m
- €0.00m
Annual cashflow statement for Neovacs SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | ARS |
| Standards: | FAS | — | FAS | — | FAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.8 | -7.55 | -6.14 | -11.8 | -3.55 |
| Depreciation | |||||
| Non-Cash Items | 0.122 | 0.117 | 0 | 0.167 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.02 | -0.668 | 0.312 | 1.76 | -1.37 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -13.3 | -8.1 | -5.65 | -9.91 | -4.45 |
| Capital Expenditures | -0.01 | -0.002 | -0.207 | -0.352 | -0.158 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.021 | 0.045 | -0.016 | -18.5 | -31.4 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.031 | 0.042 | -0.223 | -18.8 | -31.6 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.61 | 7.94 | 14.6 | 51.7 | 9.99 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.73 | -0.12 | 8.78 | 23 | -26 |